GlenLewMD

Pediatric Hematology & Oncology • Parsippany, NJ

Pediatric Hematologic Oncology

Executive Director, Clinical Development Liaison Pierre Fabre Pharmaceuticals

Join to view full profile

Dr. Lew is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lew's full profile

Already have an account?

Office
8 Campus Dr Suite 202
Parsippany, NJ 07054

Summary

Dr. Glen Lew is a pediatric hematologist-oncologist now working to help develop better treatments for cancers and blood disorders. He completed his medical education and training at Boston University School of Medicine and Emory University School of Medicine, where he also completed a fellowship in pediatric hematology/oncology. He served as an attending physician at Children's Healthcare of Atlanta for over two decades before becoming a Senior Clinical Trial Physician at Bristol Myers Squibb in 2022. He joined Pierre Fabre Pharmaceuticals in late 2024 as an Executive Director, Clinical Development Liaison. Dr. Lew has authored multiple publications with notable citation counts and has received several honors, including being recognized as a Top Doctor in Pediatric Hematology-Oncology and receiving the Young Investigator Scholar Award from the AACR.

Education & Training

Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 1997 - 2000
Emory University School of MedicineResidency, Pediatrics, 1994 - 1997
Boston University School of MedicineClass of 1994

Certifications & Licensure

GA State Medical License 1996 - 2025
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Top Doctor in Pediatric Hematology-Oncology Castle Connolly
Atlanta's Top Doctors Atlanta Magazine
Fellow's Research Award Emory University Dept. of Pediatrics
Young Investigator Scholar Award American Association for Cancer Research (AACR)
Resident's Research Award Emory University Dept. of Pediatrics
New England Pediatric Society Award
Join now to see all

Clinical Trials

Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Start of enrollment: 2004 Mar 25
ACTIVE_NOT_RECRUITING
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia Start of enrollment: 2007 Mar 01
Completed
Phase 3
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Start of enrollment: 2011 Sep 01
Completed
Phase 3
Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Start of enrollment: 2011 Sep 01
Completed
Phase 1
Music Therapy Video Development in Improving Communication, Emotional Distress, and Recovery in Adolescents/Young Adults Undergoing Treatment for High-Risk Cancer and Their Parents Start of enrollment: 2012 Apr 23
Completed
Not Applicable
Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors Start of enrollment: 2012 Nov 14
Completed
Phase 1
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas Start of enrollment: 2013 Sep 03
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

11 citations
Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-AL...
Sarah H O'Brien, Vilmarie Rodriguez, Glen Lew, Jane W Newburger, Corinna L Schultz
The Lancet. Haematology. 2024-01-01
11 citations
Body mass index during maintenance therapy and relapse risk in children with acute lymphoblastic leukemia: A Children's Oncology Group report.
Aman Wadhwa, Yanjun Chen, Lindsey Hageman, Anna L Hoppmann, Anne Angiolillo
Cancer. 2023-01-01
16 citations
Effect of a Daily Text Messaging and Directly Supervised Therapy Intervention on Oral Mercaptopurine Adherence in Children With Acute Lymphoblastic Leukemia: A Randomi...
Smita Bhatia, Lindsey Hageman, Yanjun Chen, F. Lennie Wong, Elizabeth L. McQuaid
JAMA Network Open. 2020-08-03

Professional Memberships

American Society of Hematology - ASH
Member

Industry Relationships

Executive Director, Clinical Development Liaison, Pierre Fabre Pharmaceuticals2024 - Present
Senior Clinical Trial Physician, Bristol Myers Squibb2022 - 2024